Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-α and interferon-γ in human epidermis

Journal of Investigative Dermatology

Volumn 124, Issue 4, 2005, Pages 786-792

  Hatano, Yutaka ^a   Terashi, Hiroto ^b   Arakawa, Shoko ^a   Katagiri, Kazumoto ^a  

^a OITA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ceramide; Skin; Th1 cytokines; Th2 cytokines; Transepidermal water loss

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; COMPLEMENTARY DNA; CYTOKINE; GLUCOSYLCERAMIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPID; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; ATOPIC DERMATITIS; CATALYSIS; ENZYME ACTIVITY; EPIDERMIS; HUMAN; HUMAN CELL; HYDROLYSIS; INFLAMMATORY DISEASE; LIPID ANALYSIS; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DISEASE; SKIN PERMEABILITY; SKIN WATER LOSS;

EID: 16844386596     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23651.x     Document Type: Article

References (44)

1. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 119:433-499, 2002
2. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050, 1992
3. Di Nardo A, Wertz R Giannetti A, Seidenari S: Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol (Stockholm) 78:27-30, 1998
4. Di Nardo A, Sugino K, Wertz P, Ademola J, Maibach HI: Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: A correlation study between ceramides and in vivo parameters of irritation. Contact Dermatitis 35:86-91, 1996
5. Elias PM, Feingold KR: Lipids and the epidermal water barrier: Metabolism, regulation, and pathophysiology. Semin Dermatol 11:176-182, 1992
6. Fartasch M, Bassukas IO, Diepgen TL: Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 127:221-227, 1992
7. Geilen CC, Wieder T, Orfanos CE: Ceramide signalling: Regulatory role in cell proliferation, differentiation and apoptosis in human epidermis. Arch Dermatol Res 289:559-566, 1997
8. Gfesser M, Rakoski J, Ring J: The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol 135:560-565, 1996
9. Grewe M, Bruijnzeel-Koomen CAFM, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-361, 1998
10. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchisa Y: Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119:416-423, 2002
11. Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
12. He X, Okino N, Dhami R, et al: Purification and characterization of recombinant, human acid ceramidase. J Biol Chem 278:32978-32986, 2003
13. Holleran WM, Feingold KR, Man M-Q, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991
14. Holleran WM, Ginns El, Menon GK, et al: Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 93:1756-1764, 1994a
15. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM: Permeability barrier requirements regulate epidermal beta- glucocerebrosidase. J Lipid Res 35:905-912, 1994b
16. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 91:1656-1664, 1993
17. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526, 1991
18. Jensen JM, Fölster-Holst R, Baranowsky A, et al: Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122:1423-1431, 2004
19. Jensen JM, Schütze S, Förl M, Krönke M, Proksch E: Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 104:1761-1770, 1999
20. Jump DB: Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41:41-78, 2004
21. Katagiri K, Itami S, Hatano Y, Takayasu S: Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 108:289-294, 1997
22. Kirtikara K, Laulederkind SJ, Raghow R, Kanekura T, Ballou LR: An accessory role for ceramide in interleukin-1beta induced prostaglandin synthesis. Mol Cell Biochem 181:41-48, 1998
23. Kondo H, Ichikawa Y, Imokawa G: Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 28:769-779, 1998
24. Kusuda S, Cui CY, Takahashi M, Tezuka T: Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 111:733-738, 1998
25. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 113:651-657, 2004
26. Matsuki M, Yamashita F, Ishida-Yamamoto A, et al: Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci USA 95:1044-1049, 1998
27. Matsumoto M, Umemoto N, Sugiura H, Uehara M: Difference in ceramide composition between "dry" and "normal" skin in patients with atopic dermatitis. Acta Derm Venereol (Stockholm) 79:246-247, 1999
28. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R: Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 130:452-456, 1994
29. Murata Y, Ogata J, Higaki Y, et al: Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency? J Invest Dermatol 106:1242-1249, 1996
30. Nishijima T, Tokura Y, Imokawa G, Seo N, Furukawa F, Takigawa M: Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 109:175-182, 1997
31. Sakurai K, Sugiura H, Matsumoto M, Uehara M: Occurrence of patchy parakeratosis in normal-appearing skin in patients with active atopic dermatitis and in patients with healed atopic dermatitis: A cause of impaired barrier function of the atopic skin. J Dermatol Sci 30:37-42, 2002
32. Sallusto F, Nicolo C, Maria RD, Corinti S, Testi R: Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 184:2411-2416, 1996
33. Schmuth M, Man M-Q, Weber F, et al: Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal permeability barrier homeostasis. J Invest Dermatol 115:459-466, 2000
34. Schissel SL, Schuchman EH, Williams KJ, Tabas I: Zn2 +-mediated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 271:18431-18436, 1996
35. Schwarzendruber DC, Werts PW, Madison KC, Downing DT: Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 88:709-713, 1987
36. Tagami H, Kobayashi H, Zhen XS, Kikuchi K: Environmental effects on the functions of the stratum corneum. J Investig Dermatol Symp Proc 6:87-94, 2001
37. Tavakkol A, Varani J, Elder JT, Zouboulis CC.: Maintenance of human skin in organ culture: Role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res 291:643-651, 1999
38. Terashi H, Izumi K, Rhodes LM, Marcelo CL: Human stratified squamous epithelia differ in cellular fatty acid composition. J Dermatol Sci 24:14-24, 2000
39. Tupker RA, Pinagoda J, Coenraads PJ, Nater JP: Susceptibility to irritants: Role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol 123:199-205, 1990
40. Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071-2082, 2000
41. Wakita H, Nishijima K, Tokura Y, Furukawa F, Takigawa M: Inhibitors of sphingolipid synthesis modulate Interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: Possible involvement of ceramide in biologic action of IFN-gamma. J Invest Dermatol 107:336-342, 1996
42. Wakita H, Tokura Y, Yagi H, Nishimura K, Furukawa F, Takigawa M: Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is prompted by sphingosine. Arch Dermatol Res 286:350-354, 1994
43. Wertz PW: Lipids and barrier function of the skin. Acta Derm Venereol 208:7-11, 2000
44. Yada Y, Higuchi K, Imokawa G: Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J Biol Chem 270:12677-12684, 1995